Brief: Lytix Biopharma Q1 Loss Widens To NOK 15.2 Million
May 12 (Reuters) - Lytix Biopharma AS LYTIX.OL :
* Q1 TOTAL OPERATING INCOME NOK 1.5 MILLION VERSUS NOK 21.6
MILLION YEAR AGO
* Q1 LOSS FOR PERIOD NOK 15.2 MILLION VERSUS NOK 0.4 MILLION
YEAR
AGO
Source text for Eikon: ID:nObizwQ7ma
Further company coverage: LYTIX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Lytix Biopharma AS
See all newsBrief: Lytix Biopharma Q3 Loss Widens To NOK 23.3 Mln
Brief: Lytix Biopharma Announces Interim Data On Neoadjuvant Treatment Of Melanoma
Brief: Lytix Biopharma Q1 Operating Loss Narrows To NOK 13.4 Mln
Brief: Lytix Biopharma Q4 Total Operating Income Nok 377,000
Brief: Lytix Biopharma Gets Notice Of Allowance For US Patent Application For Ltx-315 Clinical Program